FOR IMMEDIATE RELEASE
March 20, 2008
NIAID MEDIA AVAILABILITY
NIAID to Convene HIV Vaccine Summit
Watch Live Via Webcast
On Tuesday, March 25, 2008, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will host an HIV Vaccine Summit in Bethesda, Md. as an important step in the ongoing process to examine the current direction of HIV vaccine research. Through interactive panel discussions, NIAID and the scientific community will explore
Based on the panel discussions, NIAID is seeking specific recommendations on the types of research to foster and how to attract novel vaccine research ideas.
Media registration to attend the summit in-person has closed; however, media are invited to watch the summit during a live Webcast.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of
infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News
releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S.
Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research,
and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health ®
back to top
Last Updated March 20, 2008